argenx SE – American Depositary Shares (ARGX) Given Consensus Recommendation of “Strong Buy” by Brokerages

argenx SE – American Depositary Shares (NASDAQ:ARGX) has earned a consensus broker rating score of 1.00 (Strong Buy) from the four brokers that cover the stock, Zacks Investment Research reports. Four equities research analysts have rated the stock with a strong buy rating.

Brokers have set a twelve-month consensus target price of $50.67 for the company and are forecasting that the company will post ($0.38) EPS for the current quarter, according to Zacks. Zacks has also given argenx SE – American Depositary Shares an industry rank of 179 out of 265 based on the ratings given to related companies.

A number of research analysts have weighed in on the stock. Wedbush reaffirmed an “outperform” rating and set a $41.00 price target (up from $26.00) on shares of argenx SE – American Depositary Shares in a research report on Thursday, November 16th. They noted that the move was a valuation call. Zacks Investment Research cut shares of argenx SE – American Depositary Shares from a “buy” rating to a “hold” rating in a research report on Wednesday, October 25th. Finally, Piper Jaffray Companies lifted their price target on shares of argenx SE – American Depositary Shares to $100.00 and gave the company an “overweight” rating in a research report on Tuesday, December 19th.

argenx SE – American Depositary Shares (NASDAQ:ARGX) opened at $66.33 on Monday. argenx SE – American Depositary Shares has a 12-month low of $17.33 and a 12-month high of $71.40.

Several institutional investors and hedge funds have recently bought and sold shares of ARGX. Franklin Resources Inc. purchased a new stake in shares of argenx SE – American Depositary Shares during the second quarter valued at approximately $7,424,000. FMR LLC purchased a new stake in shares of argenx SE – American Depositary Shares during the second quarter valued at approximately $15,990,000. FIL Ltd purchased a new stake in shares of argenx SE – American Depositary Shares during the second quarter valued at approximately $3,182,000. VHCP Management II LLC purchased a new stake in shares of argenx SE – American Depositary Shares during the second quarter valued at approximately $13,615,000. Finally, Tekla Capital Management LLC purchased a new stake in shares of argenx SE – American Depositary Shares during the second quarter valued at approximately $1,591,000. Institutional investors own 21.60% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “argenx SE – American Depositary Shares (ARGX) Given Consensus Recommendation of “Strong Buy” by Brokerages” was originally posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/22/argenx-se-american-depositary-shares-argx-given-consensus-recommendation-of-strong-buy-by-brokerages.html.

About argenx SE – American Depositary Shares

argenx SE, a clinical-stage biopharmaceutical company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company’s lead clinical stage product candidates include ARGX-113, a product in Phase 2 clinical trials for the treatment of autoimmune diseases, including myasthenia gravis and immune thrombocytopenia; and ARGX-110, which is in Phase 1/2 clinical trials for the treatment of hematological cancers, such as T-cell lymphoma, acute myeloid leukemia, and myelodysplastic syndrome.

Get a free copy of the Zacks research report on argenx SE – American Depositary Shares (ARGX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for argenx SE - American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for argenx SE - American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply